We report a case of fungemia and disseminated disease caused by a urease-negative strain of Cryptococcus neoformans in a patient with the acquired immune deficiency syndrome. Except for failure to hydrolyze urea, the microbiological characteristics of the isolate were typical of C. neoformans. Laboratory specialists should be aware of the occurrence of atypical strains of C. neoformans, particularly those recovered from patients with the acquired immune deficiency syndrome.
Cryptococcus neoformans typically produces a chronic or subacute pulmonary, systemic, or meningeal infection and is recovered most frequently from patients with immunosuppressive disorders, including the acquired immune deficiency syndrome (8) . Although detection of cryptococcal antigen by the latex agglutination test frequently enables early institution of antimicrobial therapy in patients with suspected cryptococcal infection, isolation and rapid identification of the organism are important in disease confirmation and management. Techniques for early differentiation of C. neoformans from other genera have frequently relied on the consistent ability of C. neoformans to assimilate inositol and hydrolyze urea (1) . We report recovery of a non-ureaseproducing isolate of C. neoformans from a patient with the acquired immune deficiency syndrome and disseminated cryptococcal disease.
A 41-year-old homosexual male was admitted to our hospital with complaints of headache and incoordination of 6 weeks duration. On admission, the patient was febrile to 101°F (38.3°C); neurological examination was significant for nominal aphasia and evidence of cerebellar dysfunction. (7), urea R broth (Difco) (4), and urea broth (Rapid; Remel, Lenexa, Kans.) also failed to demonstrate hydrolysis of urea. The isolate was also referred to the Division of Mycotic Diseases at the Centers for Disease Control, Atlanta, Ga.; except for failure to hydrolyze urea on Christensen urea agar (BBL), the isolate was found to have the morphological and physiological characteristics of C. neoformans. Results of biochemical tests performed at the Centers for Disease Control included the following: (i) assimilation of glucose, cellibiose, dulcitol, galactose, inositol, raffinose, sucrose, trehalose, xylose, mannitol, and rhamnose; (ii) failure to assimilate lactose, melibiose, glycerol, or nitrate; and (iii) failure to ferment erythritol, glycerol, mannitol, and rhamnose. In addition, the isolate was found to produce brown colonies on birdseed agar, to grow at 37°C, to be susceptible to cycloheximide at a concentration of 0.5 mg/ml, to stain with a fluorescent-antibody reagent for C. neoformans in a direct fluorescent test, and to belong to serogroup A by the method of Kaplan et al. (3) . Also, the isolate was identified as C. neoformans with the API 20C yeast identification system.
Production of urease by cryptococci is remarkably consistent and has been suggested as a screening tool for this genus. Urease production has been utilized in many clinical laboratories along with other rapid tests for presumptive identification of C. neoformans. Failure to produce urease has been used in many laboratories to determine that isolates from respiratory secretions and gastric washings do not belong to the genus Cryptococcus (6) . Although 1 of the 286 strains of C. neoformans reported by Zimmer and Roberts failed to give a positive urease reaction by a rapid 15-min screening method (7), to our knowledge, this is the first report of an isolate of C. neoformans that failed to produce urease when evaluated by standard testing methods.
The identity of this isolate was initially suspected from its morphology on cornmeal-Tween agar, and although it did not hydrolyze urea, the results of other confirmatory tests (detection of phenyloxidase production and carbohydrate assimilation by the auxanographic method) were highly suggestive of C. neoformans. The organism was identified as C. neoformans with the API 20C system; however, the Uni-Yeast-Tek (Flow Laboratories) carbohydrate assimilation test 
